Cipher, Ranbaxy sales and marketing update

Ranbaxy launched Absorbica Cip-isotretinoin in the U.S. to treat severe recalcitrant nodular acne. The companies could not be reached for details. Ranbaxy has an exclusive license from Cipher to market the product to treat acne in the U.S. under a 2008 deal (see BioCentury, Aug. 18, 2008). ...